| European Case Law Identifier: | ECLI:EP:BA:2013:T039609.20130227 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 27 February 2013 | ||||||||
| Case number: | T 0396/09 | ||||||||
| Application number: | 99946470.4 | ||||||||
| IPC class: | A61K 31/15 A61K 31/155 A61K 31/16 A61K 31/175 A61K 31/195 A61K 31/275 A61K 31/40 A61K 31/44 A61K 31/50 A61K 31/655 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Fructosamine oxidase: antagonists and inhibitors | ||||||||
| Applicant name: | PhilERA New Zealand Limited | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Admissibility of the main request and auxiliary request 1 (no) Clarity and support, auxiliary request 2 (no): term 'acetylated metabolic derivative' not clear Auxiliary request 3, inventive step (yes), remittal to the first instance |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t090396eu1.html
Date retrieved: 17 May 2021